agribusinessglobal

The Evolving Role of Generics: Lessons from Chlorpyrifos

Chlorpyrifos has undergone dramatic changes in its market trajectory, from a blockbuster proprietary molecule to a globally traded generic active ingredient. AgriBusiness Global spoke with Ram ...
C&EN

Looming GLP-1 drug patent expirations draw generics firms

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
Drug Store News

Fresenius Kabi introduces generic Dalvance

Dalbavancin for injection is indicated for acute bacterial skin and skin structure infections. “Dalbavancin for injection is formulated, filled and packaged in the United States,” said Arun Verma, ...
Morningstar

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP)

ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...
CNN

FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...
Seeking Alpha

Novartis: Assessing The Impact Of Entresto Generics

Entresto generics have finally arrived in the U.S. in July, and approximately 9% of Novartis' revenue will be impacted. The growth of other key products and of Entresto in ex-U.S. territories should ...
interaksyon.philstar

‘Never out of reach’: Generics Awareness Month spotlights access to affordable, quality healthcare

This annual observance highlights the importance of generic medicines in providing affordable, effective and accessible healthcare to Filipinos. It was held under the theme “Ginhawang Generics, Ramdam ...
Wall Street Journal

Drug Tariffs Won't Affect Generics, Trump Administration Says

President Trump has delayed imposing tariffs on pharmaceuticals to allow for more negotiations with drug companies. (Francis Chung/Bloomberg News) The Trump administration says it doesn't plan to ...
STAT

Pharmalittle: We’re reading about Trump forgoing tariffs on generics, a monster MASH deal by Novo, and more

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Wall Street Journal

Trump Excludes Generics From Big Pharma Tariff Plan

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images WASHINGTON—The Trump administration said it isn’t ...
STAT

Onshoring could threaten the resilient supply chain for biosimilars and generics

Over the past six months, numerous pharmaceutical companies have announced plans to invest in new U.S. manufacturing facilities within the next decade. This so-called “onshoring,” motivated by the ...